BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2338552)

  • 1. Guanine nucleotide effects on 8-cyclopentyl-1,3-[3H]dipropylxanthine binding to membrane-bound and solubilized A1 adenosine receptors of rat brain.
    Klotz KN; Keil R; Zimmer FJ; Schwabe U
    J Neurochem; 1990 Jun; 54(6):1988-94. PubMed ID: 2338552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic visualization of A1 adenosine receptors in rat brain with [3H]8-cyclopentyl-1,3-dipropylxanthine.
    Weber RG; Jones CR; Lohse MJ; Palacios JM
    J Neurochem; 1990 Apr; 54(4):1344-53. PubMed ID: 2313291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional differences in the effect of guanine nucleotides on agonist and antagonist binding to adenosine A1-receptors in rat brain, as revealed by autoradiography.
    Fastbom J; Fredholm BB
    Neuroscience; 1990; 34(3):759-69. PubMed ID: 2352651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A1 adenosine receptor-G protein coupling in bovine brain membranes: effects of guanine nucleotides, salt, and solubilization.
    Stiles GL
    J Neurochem; 1988 Nov; 51(5):1592-8. PubMed ID: 3139838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the GTP-regulation of membrane-bound and solubilized A1-adenosine receptors.
    Ströher M; Nanoff C; Schütz W
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):87-92. PubMed ID: 2797219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the high affinity binding site for [3H]-1,3-dipropyl-8-cyclopentylxanthine in frog brain membranes.
    Oliveira JC; Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1993 Jun; 109(2):518-23. PubMed ID: 8358551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
    Gerwins P; Nordstedt C; Fredholm BB
    Mol Pharmacol; 1990 Nov; 38(5):660-6. PubMed ID: 2172773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of saponin on the binding and functional properties of the human adenosine A1 receptor.
    Cohen FR; Lazareno S; Birdsall NJ
    Br J Pharmacol; 1996 Apr; 117(7):1521-9. PubMed ID: 8730749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A1 adenosine receptors in the human fat cell: tissue distribution and regulation of radioligand binding.
    Larrouy D; Galitzky J; Lafontan M
    Eur J Pharmacol; 1991 Feb; 206(2):139-47. PubMed ID: 2065717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical modification of A1 adenosine receptors in rat brain membranes. Evidence for histidine in different domains of the ligand binding site.
    Klotz KN; Lohse MJ; Schwabe U
    J Biol Chem; 1988 Nov; 263(33):17522-6. PubMed ID: 3182861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein.
    Ramkumar V; Stiles GL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1194-200. PubMed ID: 3138408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of effects of MgCl2 and Gpp(NH)p on antagonist and agonist radioligand binding to adenosine A1 receptors.
    Finlayson K; Maemoto T; Butcher SP; Sharkey J; Olverman HJ
    Acta Pharmacol Sin; 2003 Aug; 24(8):729-40. PubMed ID: 12904270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
    Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium-dependent enhancement of endogenous agonist binding to A1 adenosine receptors: a complicating factor in quantitative autoradiography.
    Parkinson FE; Fredholm BB
    J Neurochem; 1992 Mar; 58(3):941-50. PubMed ID: 1738001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the solubilized A1 adenosine receptor from rat brain membranes.
    Klotz KN; Lohse MJ; Schwabe U
    J Neurochem; 1986 May; 46(5):1528-34. PubMed ID: 3007672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amiloride.
    Garritsen A; Ijzerman AP; Beukers MW; Soudijn W
    Biochem Pharmacol; 1990 Aug; 40(4):835-42. PubMed ID: 2143656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilized rat brain adenosine receptors have two high-affinity binding sites for 1,3-dipropyl-8-cyclopentylxanthine.
    Oliveira JC; Sebastião AM; Ribeiro JA
    J Neurochem; 1991 Oct; 57(4):1165-71. PubMed ID: 1895101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of an adenosine A1 receptor agonist and adenosine A1 receptor antagonist to sheep pineal membranes.
    Falcón J; Privat K; Ravault JP
    Eur J Pharmacol; 1997 Oct; 337(2-3):325-31. PubMed ID: 9430432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity chromatography of A1 adenosine receptors of rat brain membranes.
    Nakata H
    Mol Pharmacol; 1989 Jun; 35(6):780-6. PubMed ID: 2733695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.